ASPIRE (Aub-haS2 Plus bIomaRkErs)
ConditionPerioperative Medicine
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorHospital Samaritano Paulista
About this trial
ASPIRE is a prospective, multicenter, observational study that will assess the performance of AUB-HAS2 to predict the occurrence of major adverse cardiovascular events 30-days after a non-cardiac surgery and the additional role of high-sensitivity troponin T and NT-ProBNP biomarkers in the accuracy of different event prediction indexes after non-cardiac procedures.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 40 years, in the preoperative period of non-cardiac procedures, with expected hospitalization for at least 24 hours postoperatively.
Disqualifiers
Refusal to sign the informed consent form.
Trial population
Patients ≥ 40 years, that will undergo non-cardiac procedures, with expected hospitalization for at least 24 hours postoperatively.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
RATE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS
COMPOSITE OF DEATH, MYOCARDIAL INFARCTION AND STROKE
Time frame
30 daysSecondary outcomes
1
RATE OF MYOCARDIAL INJURY
Time frame
30 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: